Growing community of inventors

Amsterdam, Netherlands

Mark Jeroen Kwakkenbos

Average Co-Inventor Count = 5.06

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 55

Mark Jeroen KwakkenbosTim Beaumont (16 patents)Mark Jeroen KwakkenbosHergen Spits (9 patents)Mark Jeroen KwakkenbosSanjeev Mariathasan (7 patents)Mark Jeroen KwakkenbosEric J Brown (7 patents)Mark Jeroen KwakkenbosJohn Hiroshi Morisaki (7 patents)Mark Jeroen KwakkenbosWouter L W Hazenbos (7 patents)Mark Jeroen KwakkenbosKimberly Kajihara (7 patents)Mark Jeroen KwakkenbosYi Xia (7 patents)Mark Jeroen KwakkenbosAdrianus Quirinus Bakker (5 patents)Mark Jeroen KwakkenbosEtsuko Yasuda (3 patents)Mark Jeroen KwakkenbosKoen Wagner (3 patents)Mark Jeroen KwakkenbosPaula Maria Wilhelmina Van Helden (1 patent)Mark Jeroen KwakkenbosArjen Quirinus Bakker (1 patent)Mark Jeroen KwakkenbosHergen Spits (0 patent)Mark Jeroen KwakkenbosWouter LW Hazenbos (0 patent)Mark Jeroen KwakkenbosMark Jeroen Kwakkenbos (17 patents)Tim BeaumontTim Beaumont (29 patents)Hergen SpitsHergen Spits (25 patents)Sanjeev MariathasanSanjeev Mariathasan (16 patents)Eric J BrownEric J Brown (12 patents)John Hiroshi MorisakiJohn Hiroshi Morisaki (11 patents)Wouter L W HazenbosWouter L W Hazenbos (7 patents)Kimberly KajiharaKimberly Kajihara (7 patents)Yi XiaYi Xia (7 patents)Adrianus Quirinus BakkerAdrianus Quirinus Bakker (16 patents)Etsuko YasudaEtsuko Yasuda (9 patents)Koen WagnerKoen Wagner (5 patents)Paula Maria Wilhelmina Van HeldenPaula Maria Wilhelmina Van Helden (4 patents)Arjen Quirinus BakkerArjen Quirinus Bakker (1 patent)Hergen SpitsHergen Spits (0 patent)Wouter LW HazenbosWouter LW Hazenbos (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Aimm Therapeutics B.v. (12 from 22 patents)

2. Genentech, Inc. (7 from 3,221 patents)

3. Medimmune Limited (3 from 541 patents)

4. Kling Biotherapeutics B.v. (1 from 4 patents)


17 patents:

1. 12084681 - Ex vivo antibody production

2. 10730931 - RSV-specific binding molecules and means for producing them

3. 10611829 - Means and methods for producing stable antibodies

4. 10344076 - Means and methods for producing high affinity antibodies

5. 10059757 - RSV-specific binding molecules and means for producing them

6. 9969795 - Means and methods for producing high affinity antibodies

7. 9927428 - Gram-positive bacteria specific binding compounds

8. 9718874 - Influenza A virus specific antibodies

9. 9688745 - Gram-positive bacteria specific binding compounds

10. 9458228 - Gram-positive bacteria specific binding compounds

11. 9399673 - Gram-positive bacteria specific binding compounds

12. 9321831 - RSV-specific binding molecules and means for producing them

13. 9273118 - Means and methods for producing high affinity antibodies

14. 9266943 - Gram-positive bacteria specific binding compounds

15. 9206247 - Means and methods for producing high affinity antibodies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…